Seeking Alpha·2d ago
MannKind Corporation (MNKD) Q3 2026 Earnings Call TranscriptMannKind Corporation (MNKD) Q3 2026 Earnings Call Transcript
MannKind's revenue momentum is accelerating, with 2026Q2 revenue up 42.9% YoY to $109.4M, driven by Tyvaso DPI royalties and Afrezza growth, yet operating leverage has reversed as SG&A surged 84.5% YoY to $58.3M, pushing operating income to a -$350K loss.
Price trend, volume and key moving averages
Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 5, 2026 | -$0.01+84.5% vs -$0.06 | $102M-5.4% vs $108M |
Q3 2026 Aug 5, 2026 | -$0.06-700.0% vs -$0.01 | $109M+1.2% vs $108M |
Q2 2026 May 6, 2026 | -$0.05-150.0% vs -$0.02 | $90M-14.4% vs $105M |
Q1 2026 Feb 26, 2026 | -$0.05-400.0% vs -$0.01 | $112M+14.7% vs $98M |
MannKind Corporation (MNKD) Q3 2026 Earnings Call Transcript
MannKind (NASDAQ: MNKD) expects to return to profitability in the fourth quarter after reporting higher third-quarter revenue and a net loss, as the company's FUROSCIX ReadyFlow and pediatric Afrezza launches gain traction. Revenue rose 24% to $101.9 million from $82.1 million a year earlier, Chief Financial Officer Chris Prentiss said on the company's Nov. 5 earnings
Although the revenue and EPS for MannKind (MNKD) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
MannKind (MNKD) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.03 per share a year ago.
Benchmark MNKD against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for MannKind Corporation (MNKD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $3.90 | $1.25B | -16.69 | 22.23% | -18.1% | — | — | |
| $562.02 | $23.86B | 20.69 | 10.61% | 38.61% | 19.18% | — | |
| $114.41 | $24.8B | -41.33 | 66.73% | -39.85% | -82.75% | — | |
| $21.23 | $3.64B | 10.28 | 11.87% | 30.13% | 28.03% | — | |
| $65.44 | $5.43B | -51.55 | 114.51% | -9.17% | — | — | |
| $15.43 | $1.52B | -3.01 | 20.13% | -71.78% | — | — |
MannKind Corporation (MNKD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
MannKind Corporation (MNKD) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 5, 2026·SEC
Jul 24, 2026·SEC
Jun 2, 2026·SEC
Get notified when MNKD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
MannKind Corporation (MNKD) stock FAQ — growth, dividends, profitability & financials explained
MannKind Corporation (MNKD) reported $413.4M in revenue over the trailing twelve months. Revenue was $349.0M in fiscal year 2025.
MannKind Corporation (MNKD) grew revenue by 31.7% over the trailing twelve months, compared with the twelve months before.
No. MannKind Corporation (MNKD) reported a net loss of $74.8M over the trailing twelve months.
MannKind Corporation (MNKD) had negative free cash flow of $78.7M over the trailing twelve months.
